These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 36503024
1. Midterm Results of Drug-Coated Balloon Alone or Combined with Rotarex Thrombectomy Device for Treatment of Subacute Femoropopliteal Artery Thrombotic Occlusion. Fan W, Lu S, Tan J, Cui X, Liang K, Zhu L, He Q, Yu B, Shi W. Ann Vasc Surg; 2023 May; 92():240-248. PubMed ID: 36503024 [Abstract] [Full Text] [Related]
2. Combination of Percutaneous Rotational Thrombectomy and Drug-Coated Balloon for Treatment of Femoropopliteal Artery Nonembolic Occlusion: 12-Month Follow-up. Wang Q, Zhu RM, Ren HL, Leng R, Zhang WD, Li CM. J Vasc Interv Radiol; 2020 Oct; 31(10):1661-1667. PubMed ID: 32921564 [Abstract] [Full Text] [Related]
3. Combination of Rotarex Thrombectomy and Drug-Coated Balloon for the Treatment of Femoropopliteal Artery In-Stent Restenosis. Liao CJ, Song SH, Li T, Zhang Y, Zhang WD. Ann Vasc Surg; 2019 Oct; 60():301-307. PubMed ID: 31075447 [Abstract] [Full Text] [Related]
4. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes. Rodoplu O, Oztas DM, Meric M, Beyaz MO, Ulukan MO, Yildiz CE, Unal O, Ugurlucan M. Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329 [Abstract] [Full Text] [Related]
8. Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study. Jia S, Liu J, Sun G, Zhang J, Zhuang B, Jia X, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W, AcoArt I Trial Investigators,. Ann Vasc Surg; 2022 May; 82():70-80. PubMed ID: 34902474 [Abstract] [Full Text] [Related]
11. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions. Yiğit G. Vascular; 2022 Aug; 30(4):739-748. PubMed ID: 34180304 [Abstract] [Full Text] [Related]
12. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis. Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ. Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634 [Abstract] [Full Text] [Related]
13. Recanalization of acute and subacute femoropopliteal artery occlusions with the rotarex catheter: one year follow-up, single center experience. Duc SR, Schoch E, Pfyffer M, Jenelten R, Zollikofer CL. Cardiovasc Intervent Radiol; 2005 Jun; 28(5):603-10. PubMed ID: 16132388 [Abstract] [Full Text] [Related]
14. Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study). Shishehbor MH, Zeller T, Werner M, Brodmann M, Parise H, Holden A, Lichtenberg M, Parikh SA, Kashyap VS, Pietras C, Tirziu D, Ardakani S, Beschorner U, Krishnan P, Niazi KA, Wali AU, Lansky AJ. Circulation; 2022 May 31; 145(22):1645-1654. PubMed ID: 35377157 [Abstract] [Full Text] [Related]
15. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions. Kokkinidis DG, Jawaid O, Cantu D, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Armstrong EJ. J Endovasc Ther; 2020 Jun 31; 27(3):492-501. PubMed ID: 32364000 [Abstract] [Full Text] [Related]
16. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial. Iida O, Soga Y, Urasawa K, Saito S, Jaff MR, Wang H, Ookubo H, Yokoi H, MDT-2113 SFA Japan Investigators. J Endovasc Ther; 2018 Feb 31; 25(1):109-117. PubMed ID: 29264999 [Abstract] [Full Text] [Related]
17. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E. J Endovasc Ther; 2014 Jun 31; 21(3):359-68. PubMed ID: 24915582 [Abstract] [Full Text] [Related]
18. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I. Xu Y, Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F, Zhao Y, Guo P, Bi W, Wang S, Guo W. JACC Cardiovasc Interv; 2018 Dec 10; 11(23):2347-2353. PubMed ID: 30448170 [Abstract] [Full Text] [Related]
19. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K. J Endovasc Ther; 2016 Jun 10; 23(3):409-16. PubMed ID: 27117972 [Abstract] [Full Text] [Related]
20. Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion. Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, POPCORN Investigators. J Am Heart Assoc; 2023 Jan 03; 12(1):e025677. PubMed ID: 36583431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]